Similar articles

• [Clinical research on the hypolipidemic action of a probucol preparation].

  Naumova R, Kerekovska M, Goranov I, Balabanski L. Naumova R, et al. Vutr Boles. 1986;25(2):73-7. Vutr Boles. 1986. PMID: 3716382 Bulgarian.
• [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].

  Rouffy J, Chanu B, Bakir R, Goy-Loepper J, Saya C. Rouffy J, et al. Nouv Presse Med. 1980 Oct 30;9(40):3014-7. Nouv Presse Med. 1980. PMID: 7443443 French.
• Effect of probucol on plasma lipids and lipoproteins in type IIb hyperlipoproteinemia.

  Hunninghake DB, Bell C, Olson L. Hunninghake DB, et al. Atherosclerosis. 1980 Nov;37(3):469-74. doi: 10.1016/0021-9150(80)90153-7. Atherosclerosis. 1980. PMID: 7458992
• [Probucol : comparison of its effect with that of a placebo in hyperlipoproteinemia type II].

  Beaumont V. Beaumont V. Nouv Presse Med. 1980 Oct 30;9(40):3011-3. Nouv Presse Med. 1980. PMID: 7443442 Clinical Trial. French. No abstract available.
• [Probucol, HDL and inverse transport of cholesterol].

  [No authors listed] [No authors listed] Med Clin (Barc). 1989 Oct 28;93(13):22-3 p.. Med Clin (Barc). 1989. PMID: 2695695 Review. Spanish. No abstract available.